Scrip Dallas bought MRAI

November 7, 2025 · Form 4 insider transaction

Scrip Dallas bought 200,000 shares of Marpai, Inc., a transaction worth N/A. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 5 days after the transaction.

Direction
Acquired (buy-side)
Shares
200,000
Price
N/A
Total value
N/A
Role
SecurityCommon Warrants to purchase Shares of Common Stock
Transaction codeP: Open-market purchase
Transaction dateNovember 7, 2025
Filing dateNovember 12, 2025
Shares owned after200,000
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

On November 7, 2025, Marpai Inc. (the "Company") entered into a Securities Purchase Agreement for a private placement offering, in which the reporting person purchased 100,000 shares of common stock of the Company and common warrants to purchase up to 200,000 shares of common stock of the Company. The purchase price for each share of common stock and accompanying common warrant is $1.00. The common warrants have an exercise price of $1.00 per share, can be exercised immediately following the closing of the private placement offering and will be exercisable for three years following the date of issuance.; The securities are held by the Dallas S. Scrip and Michelle R. Script Trust, of which the reporting person and spouse are co-trustees and share investment and voting control.

View the original Form 4 on SEC EDGAR